Wealthfront beats EPS estimates, revenue growth slows to 0.9%

Wealthfront shares rose 7.9% to $10.21 after the company reported first-quarter results that surpassed expectations. The firm generated $0.10 in earnings per share, a $0.01 improvement over the $0.09 consensus estimate. Total revenue for the period reached $91.87 million, marking a 0.9% increase from the same quarter last year. The stock traded as high as $10.23 before settling at the close.

Trading activity was notably subdued compared to recent averages. Approximately 527,726 shares changed hands during the session, representing a 65% decline from the average session volume of 1,496,695 shares. The previous closing price stood at $9.46. According to data from GN stocks/nasdaq, the company maintains a market capitalization of $1.53 billion, though its negative price-to-earnings ratio of -9.98 reflects ongoing profitability challenges.

Institutional investors maintain mixed positions

Recent filings show varied institutional interest in the company. Royal Bank of Canada established a new position valued at $27,000 in the first quarter, while Barclays PLC added a stake worth approximately $136,000 in the fourth quarter. Sandia Investment Management LP opened a position of about $44,000 in the fourth quarter, and Squarepoint Ops LLC acquired shares worth $90,000 in the second quarter. These moves contrast with corporate insiders who have reduced their holdings significantly over the last three months.

Insider selling has been a consistent trend. Vice President Kal Iyer sold 28,498 shares at $8.46 per share on June 17, reducing their stake by 11.21%. Chief Technology Officer Julien Wetterwald sold 39,810 shares at the same price, decreasing his ownership by 5.19%. Both transactions were executed under pre-arranged Rule 10b5-1 trading plans. In total, insiders have sold 136,565 shares worth $1,193,520 in the past three months, although they still retain 27.36% of the company’s stock.

Analyst sentiment remains divided on valuation

Research firms have issued conflicting views on the stock’s future performance. Goldman Sachs maintained a neutral rating with a $10.00 price target, while Royal Bank of Canada set a higher objective of $11.00. Conversely, Wells Fargo lowered its target from $12.00 to $11.50 while keeping an overweight recommendation. Weiss Ratings issued a sell rating on July 6, and Wall Street Zen upgraded its stance from sell to hold on July 18. The current average rating across nine analysts is Hold, with a mean price target of $12.00.

Technical indicators suggest recent volatility

The stock’s 50-day moving average is currently $9.33, while the 200-day moving average sits at $9.61. The recent price action has pushed the share price above both benchmarks, indicating a short-term bullish shift. However, the negative P/E ratio highlights that the company is not yet profitable on a trailing basis. The 7.9% gain brings the stock closer to the average analyst target, but the low trading volume suggests limited institutional participation in the recent price move.